Search
Advanced Search
Toggle navigation
Home
Journals & eBooks
Browse Journals by Subject
Browse Journals by Title
Browse Patent Journals
Free Online Samples
Journals Impacting Science
New Titles 2021
New Titles 2020
Price and Ordering Information
Subscription Rates 2021
Subscription Rates 2020
eBooks Website
Browse eBooks by Subject
Browse eBooks by Title
Browse Video Books
Journals and eBooks Catalog
Free Online Trials
Endorsements
Articles by Disease
Marketing Opportunities
Institutional Membership
Advertise With Us
Journals and eBooks Catalog
Media-Pack-2020
Author's Benefits Guide
Events by Region
Events by Subject Areas
Exhibit Schedule
Healthcare Industry Resources
Media Partners
Partnering Events
Promotional Services
For Authors, Editors & Librarians
Author Benefits
Author's Benefits Guide
Author Reprints
Authorship
Copyediting Services
Editorial Policies
FAQs for e-prints/reprints
Increase Visibility of your Article
General FAQs
Guidelines for Guest Editors
Journal Catalog 2020
Journal Catalog 2021
Kudos
Library Recommendations
Manuscript Transfer Facility
Online Manuscript Submission
Order Bulk ePrints
Order Bulk Reprints
Publication Cycle - Process Flowchart
Publishing Ethics
Peer Review
Self-Archiving Policies
Table of Contents Alert
Trial Requests
Webinars
Contact Us
Track Your Manuscript:
Enter Correct Manuscript Reference Number:
Submit Reference Number
Current Cancer Drug Targets
Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Impact Factor:
2.912
5 Year Impact Factor:
2.947
Subscribe to this Journal
Call for Editors
Book Proposal
Join Editorial Board
New Journal Proposal
Become a Reviewer
Become an Executive Guest Editor
Thematic Issue Proposal
Submit Abstract Online
Contents
Current Cancer Drug Targets
,
Volume 18
- Number 8
Biography
Open Access
Meet Our Editorial Board Member
,
18
(
8
):
719
M. Haber
DOI:
10.2174/156800961808180829102109
View Biography
Download Free
Review Article
The Safety, Efficacy and Therapeutic Potential of Histone Deacetylase Inhibitors with Special Reference to Panobinostat in Gastrointestinal Tumors: A Review of Preclinical and Clinical Studies
,
18
(
8
):
720
- 736
Avineesh Singh, Preeti Patel, Jageshwar, Vijay Kumar Patel, Deepak Kumar Jain, M. Kamal and Harish Rajak*
DOI:
10.2174/1568009617666170630124643
×
The Safety, Efficacy and Therapeutic Potential of Histone Deacetylase Inhibitors with Special Reference to Panobinostat in Gastrointestinal Tumors: A Review of Preclinical and Clinical Studies
View Abstract
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Review Article
Significant Role of MUC1 in Development of Resistance to Currently Existing Anti-cancer Therapeutic Agents
,
18
(
8
):
737
- 748
Leila Farahmand, Parnaz Merikhian, Neda Jalili, Behrad Darvishi and Keivan Majidzadeh-A*
DOI:
10.2174/1568009617666170623113520
×
Significant Role of MUC1 in Development of Resistance to Currently Existing Anti-cancer Therapeutic Agents
View Abstract
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Review Article
p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents
,
18
(
8
):
749
- 772
Surendra Kumar Nayak*, Gopal L. Khatik, Rakesh Narang, Vikramdeep Monga and Harish Kumar Chopra
DOI:
10.2174/1568009617666170623111953
×
p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents
View Abstract
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Review Article
Therapeutic Approaches for the Treatment of Epidermal Growth Factor Receptor Mutated Lung Cancer
,
18
(
8
):
773
- 791
Dhaval Sanchala, Lokesh K. Bhatt* and Kedar S. Prabhavalkar
DOI:
10.2174/1568009617666170623123848
×
Therapeutic Approaches for the Treatment of Epidermal Growth Factor Receptor Mutated Lung Cancer
View Abstract
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Review Article
Development of Drug Targeting and Delivery in Cervical Cancer
,
18
(
8
):
792
- 806
Urvashi Aggarwal, Amit Kumar Goyal and Goutam Rath*
DOI:
10.2174/1568009617666171009165105
×
Development of Drug Targeting and Delivery in Cervical Cancer
View Abstract
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Research Article
A High-throughput Quantitative Expression Analysis of Cancer-related Genes in Human HepG2 Cells in Response to Limonene, a Potential Anticancer Agent
,
18
(
8
):
807
- 815
Rand R. Hafidh*, Saba Z. Hussein, Mohammed Q. MalAllah, Ahmed S. Abdulamir and Fatimah Abu Bakar
DOI:
10.2174/1568009617666171114144236
×
A High-throughput Quantitative Expression Analysis of Cancer-related Genes in Human HepG2 Cells in Response to Limonene, a Potential Anticancer Agent
View Abstract
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Research Article
JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells
,
18
(
8
):
816
- 828
Ilaria Zanellato*, Donato Colangelo and Domenico Osella
DOI:
10.2174/1568009617666170623101722
×
JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells
View Abstract
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board
COPE Compliant
About the Journal
⇨ Journal Home
⇨ Editorial Policies
⇨ Editorial Board
⇨ Meet the Executive Guest Editor(s)
⇨ Board Recruitment Workflow
⇨ Join Editorial Board
⇨ Indexing Information
⇨ Announcements
⇨ Endorsements
⇨ Authors' Comments
For Authors
⇨ Author Guidelines
⇨ Animated Abstracts
⇨ Increase Visibility of your Article
⇨ Submit Abstracts Online
⇨ Submit Manuscripts Online
⇨ Open Access Funding
⇨ Publishing Ethics and Rectitude
⇨ Archiving Policies
⇨ Manuscript Transfer Facility
For Guest Editors
⇨ Thematic Issue Proposal
⇨ Forthcoming Thematic Issues
⇨ Guest Editor Guidelines
For Reviewers
⇨ Reviewer Guidelines
⇨ Peer Review Workflow
⇨ Become a Reviewer
For Librarians & Readers
⇨ Contents & Abstracts
⇨ Open Access Articles
⇨ Editor's Choice
⇨ Free Copies Online
⇨ Thematic Issues
⇨ Journal Catalog 2020
⇨ Journal Catalog 2021
⇨ Most Accessed Articles
⇨ Most Cited Articles
⇨ PURCHASE ARTICLES
⇨ Order Reprints
⇨ Subscribe
⇨ Trial Requests
⇨ Library Recommendation
Quick Links
⇨ Journal's New Website
⇨ Advertise with Us
⇨ Brand Ambassadors
⇨ Newsletter
⇨ Download PDF Flyer
⇨ Table of Contents Alert
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Advertisement
Related Journals
view more >>
Related eBooks
view more >>
eBooks Catalog
view eBooks Catalog >>
Webmaster Contact:
info@benthamscience.net
Copyright © 2021 Bentham Science
|
Privacy Policy